These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20558357)

  • 21. Hepatocellular carcinoma screening and diagnosis.
    Sherman M; Colombo M
    Semin Liver Dis; 2014 Nov; 34(4):389-97. PubMed ID: 25369301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions.
    Kudo M
    Semin Liver Dis; 1999; 19(3):297-309. PubMed ID: 10518309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of de novo hepatocellular carcinoma in patients on a liver transplant list: frequency, size, and assessment of current screening methods.
    Van Thiel DH; Yong S; Li SD; Kennedy M; Brems J
    Liver Transpl; 2004 May; 10(5):631-7. PubMed ID: 15108254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
    De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
    Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.
    Khalili K; Kim TK; Jang HJ; Haider MA; Khan L; Guindi M; Sherman M
    J Hepatol; 2011 Apr; 54(4):723-8. PubMed ID: 21156219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatocellular carcinoma in cirrhosis: semeiology and performance of magnetic resonance imaging and lipiodol computed tomography].
    Marcato N; Abergel A; Alexandre M; Boire JY; Darcha C; Duchène B; Chipponi J; Boyer L; Viallet JF; Bommelaer G
    Gastroenterol Clin Biol; 1999 Jan; 23(1):114-21. PubMed ID: 10219612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of computed tomography and magnetic resonance imaging in diagnosis and differential diagnosis of small hepatocellular carcinoma].
    Ma Y; Zhang XL; Li XY; Zhang L; Su HH; Zhan CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2235-8. PubMed ID: 19114368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging diagnosis and staging of hepatocellular carcinoma.
    Lee JM; Trevisani F; Vilgrain V; Wald C
    Liver Transpl; 2011 Oct; 17 Suppl 2():S34-43. PubMed ID: 21739567
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.
    Hennedige T; Venkatesh SK
    World J Gastroenterol; 2016 Jan; 22(1):205-20. PubMed ID: 26755871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of hepatocellular carcinoma and early diagnosis.
    Limaye AR; Cabrera R
    Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging and hepatocellular carcinoma.
    Cooper JN
    Gastroenterol Clin North Am; 1987 Dec; 16(4):591-9. PubMed ID: 2831152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology.
    Kim TK; Jang HJ; Wilson SR
    Clin Liver Dis; 2005 May; 9(2):253-79. PubMed ID: 15831272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EUS for detection of the hepatocellular carcinoma: results of a prospective study.
    Singh P; Erickson RA; Mukhopadhyay P; Gopal S; Kiss A; Khan A; Ulf Westblom T
    Gastrointest Endosc; 2007 Aug; 66(2):265-73. PubMed ID: 17543307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
    Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the imaging of hepatocellular carcinoma.
    You MW; Kim SY; Kim KW; Lee SJ; Shin YM; Kim JH; Lee MG
    Clin Mol Hepatol; 2015 Mar; 21(1):95-103. PubMed ID: 25834808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern hepatic imaging.
    Braga L; Guller U; Semelka RC
    Surg Clin North Am; 2004 Apr; 84(2):375-400. PubMed ID: 15062651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls.
    Baron RL; Peterson MS
    Radiographics; 2001 Oct; 21 Spec No():S117-32. PubMed ID: 11598252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early imaging diagnosis of primary liver cancer].
    Long LL; Peng P; Huang ZK
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):329-332. PubMed ID: 28763836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical resection for small hepatocellular carcinoma in cirrhosis: the Eastern experience.
    Kishi Y; Hasegawa K; Kokudo N
    Recent Results Cancer Res; 2013; 190():69-84. PubMed ID: 22941014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.